Alexis LaChapelle

Alexis LaChapelle, B.A.
Research Assistant II from June 2005 to April 2008

Alexis graduated in 2005 from Willamette University with a BA in Biology and worked in the Hoatlin lab for 3 years. She often came up with unlikely excuses for not going into work, such as claiming she was in the ER. Twice. She is currently enrolled in the Physician Assistant program at OHSU.

Email: alexislachapelle AT gmail DOT com

Publications

 * LaChapelle, A. M., Ruygrok, M. L., Toomer, ME., Oost, J. J., Monnie, M. L., Swenson, J. A., Compton, A. A., Stebbins-Boaz-, B. 2006. The hormonal herbicide, 2,4-dichlorophenoxyacetic acid, inhibits Xenopus oocyte maturation by targeting translational and post-translational mechanisms. Reprod. Toxicol. 2007 Jan;23(1):20-31.


 * Stebbins-Boaz, B., Compton, A., LaChapelle, A., Monnie, M., Oost, J., Ruygrok, M., Swenson, J. 2005. The hormonal herbicide, 2,4-D, induces a signaling response in Xenopus oocytes that interferes with meiotic maturation in vitro. Mol. Biol. Cell 16S:741a.


 * Landais I, Sobeck A, Stone S, LaChapelle A, and Hoatlin ME. A novel cell-free screen identifies a potent inhibitor of the Fanconi anemia pathway, Int J Cancer. 2008.

Abstracts

 * 2006	IMMUNOISOLATION AND PARTIAL CHARACTERIZATION OF FANCONI ANEMIA PROTEIN COMPLEXES IN XENOPUS EGG EXTRACTS. S.Stone, A.Sobeck, A.LaChapelle, H.Joenje, W.Wang, M.E.Hoatlin. 18th Annual Fanconi Anemia Research Fund Scientific Symposium Bethesda, MD.


 * 2006	SEQUENTIAL RECRUITMENT OF FANCONI ANEMIA PROTEINS TO REPLICATING CHROMATIN. A.Sobeck, S.Stone, A.LaChapelle, M.E.Hoatlin. (Platform presentation) 11th Annual Xenopus Conference, Chiba, Japan.


 * 2006	A CELL-FREE ASSAY TO SCREEN FOR COMPOUNDS THAT MODULATE THE FANCONI/BRCA PATHWAY. (Poster) Stacie Stone, Alexandra Sobeck, Igor Landais, Alexis LaChapelle, and Maureen E. Hoatlin. 48th Annual Hematology Society Meeting. Orlando, FL.


 * 2006	A CELL-FREE ASSAY TO SCREEN FOR COMPOUNDS THAT MODULATE THE FANCONI/BRCA PATHWAY (Poster). Igor Landais, Stacie Stone, Alexandra Sobeck,, Alexis LaChapelle, and Maureen E. Hoatlin. 18th Annual Fanconi Anemia Research Fund Scientific Symposium, Bethesda, MD.


 * 2006	A XENOPUS CELL-FREE ASSAY FOR SCREENING OF COMPOUNDS THAT MODULATE THE FANCONI ANEMIA PATHWAY (Poster). Igor Landais, Alexandra Sobeck, Stacie Stone, Alexis LaChapelle, and Maureen E. Hoatlin. 18th Annual Fanconi Anemia Research Fund Scientific Symposium, Bethesda, MD.


 * 2007 	A NOVEL CELL-FREE SCREEN FOR DRUGS THAT MODULATE THE HUMAN FANCONI/BREAST CANCER SUSCEPTIBILITY PROTEIN NETWORK (Poster, Eli Lilly-AACR Scholar-in-training award). Landais I, Sobeck A, Stone S, LaChapelle A, Hoatlin ME. AACR-NCI-EORTC International Conference, Molecular Targets and Cancer Therapeutics. San Francisco, CA.


 * 2007	DIFFERENTIAL ACTIVATION OF CORE COMPLEX MEMBER FANCM AND DOWNSTREAM TARGET FANCD2 (Oral presentation by Postdoctoral Fellow, A. Sobeck). Sobeck A, Stone S, LaChapelle A, Landais I, Hoatlin ME. 19th Annual Fanconi Anemia Research Fund Scientific Symposium, Chicago, IL.


 * 2007	IDENTIFICATION OF A NOVEL PARTNER FOR FANCM (Oral presentation by Graduate Student, S. Stone). Stone S, Sobeck A, LaChapelle A, Landais I, W. Wang, Hoatlin ME. 19th Annual Fanconi Anemia Research Fund Scientific Symposium, Chicago, IL.

Back to Main Page Hoatlin Lab